Abstract
IntroductionSpinal cord stimulation is emerging as a minimally invasive technique for treatment of persistent spinal pain syndrome (PSPS).MethodsWe describe a case series of 25 individuals with PSPS who underwent implantation of a spinal cord stimulator device between 2017 and 2021.ResultsThere was a significant reduction in mean visual analog scale pain scores in the immediate postoperative phase, (8.61 vs. 2.3, p < 0.001). There were twelve patients who consumed pre-operative opioid, and 75% showed reduction of use with a significantly lower average daily dose (66.8 vs. 26.9 meq/D, p < 0.05). There was a significant reduction in the Oswestry Disability Index during postoperative follow-up visits (p < 0.001). There were no major perioperative or long-term complications from the procedure in follow-up.ConclusionThe analysis of this cohort suggests successful long-term treatment of a diverse set of patients with PSPS who underwent spinal cord stimulation (SCS) and had meaningful improvement in quality of life and reduction in opioid consumption.
Highlights
Spinal cord stimulation is emerging as a minimally invasive technique for treatment of persistent spinal pain syndrome (PSPS)
We describe a retrospective case series of patients with type 1 persistent spinal pain syndrome” (PSPS) and 2 with axial pain not associated to radicular pain or other pain syndromes like complex regional pain syndrome (CRPS) and persistent radicular pain post spinal surgery and treated with spinal cord stimulation, for which we reviewed postoperative outcomes including the use of prescription opioid analgesics, pain score, and disability score
Spinal cord stimulation (SCS) has been widely studied, and different indications have emerged over the years
Summary
Spinal cord stimulation is emerging as a minimally invasive technique for treatment of persistent spinal pain syndrome (PSPS). Improvement in stimulator technology is thought to have led to resurgence in use since 2005, when positive randomized control trials showed efficacy in treatment of patients with failed back surgery syndrome (FBSS) [2–4]. Neuropathic pain is felt to be secondary to a spinal abnormality that does not have a radicular pattern and includes some forms of FBSS. The mechanism of PSPS is a complex interaction of surgical factors (surgical complications, namely, hardware failure, infection, Spinal Cord Stimulation and Opioid and hematoma) and other predisposing factors (psychosocial and anatomical factors). This can lead to exacerbation of preexisting spinal pathology causing nociceptive or neuropathic pain [5]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
